SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
02-Aug-18 4:07 PM View: | Miller Vincent A. Chief Medical Officer | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 30,993 | $137.00 | $4,246,040.00 | (100%) 30.99K to 0 | 0% |
02-Aug-18 4:04 PM View: | Cox Troy President and CEO Director | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (other) | 206,847 | $137.00 | $28,338,000.00 | (85%) 242.07K to 35.22K | 0% |
02-Aug-18 4:09 PM View: | Ryan Jason Chief Financial Officer | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (other) | 42,215 | $137.00 | $5,783,460.00 | (86%) 49.17K to 6.96K | 0% |
02-Aug-18 7:08 PM View: | Roche Holdings Inc Director 10% Owner | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Market Purchase | 16,221,000 | $137.00 | $2,222,279,936.00 | 77% 21.02M to 37.24M | 0% |
02-Aug-18 4:06 PM View: | Hesslein Robert W. SVP and General Counsel | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 76,494 | $137.00 | $10,479,700.00 | (100%) 76.49K to 0 | 0% |
02-Aug-18 4:08 PM View: | Nallicheri Melanie Chief Business Officer | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 19,074 | $137.00 | $2,613,140.00 | (100%) 19.07K to 0 | 0% |
02-Aug-18 4:07 PM View: | Jones Evan/ Fa Director | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 17,652 | $137.00 | $2,418,320.00 | (65%) 26.95K to 9.3K | 0% |
02-Aug-18 4:10 PM View: | Yeshwant Krishna Director | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 5,786 | $137.00 | $792,682.00 | (100%) 5.79K to 0 | 0% |
02-Aug-18 4:04 PM View: | Cox Troy President and CEO Director | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 35,221 | $137.00 | $4,825,280.00 | (100%) 35.22K to 0 | 0% |
02-Aug-18 4:09 PM View: | Ryan Jason Chief Financial Officer | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 6,955 | $137.00 | $952,835.00 | (100%) 6.96K to 0 | 0% |
02-Aug-18 4:05 PM View: | Dougherty Michael R Director | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (other) | 12,669 | $137.00 | $1,735,650.00 | (51%) 24.79K to 12.12K | 0% |
02-Aug-18 4:04 PM View: | Doherty Michael J Head of Product Development | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (other) | 65,332 | $137.00 | $8,950,480.00 | (80%) 81.29K to 15.96K | 0% |
02-Aug-18 4:07 PM View: | Miller Vincent A. Chief Medical Officer | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (other) | 36,186 | $137.00 | $4,957,480.00 | (54%) 67.18K to 30.99K | 0% |
02-Aug-18 4:08 PM View: | Nallicheri Melanie Chief Business Officer | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (other) | 46,937 | $137.00 | $6,430,370.00 | (71%) 66.01K to 19.07K | 0% |
02-Aug-18 4:07 PM View: | Jones Evan/ Fa Director | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 9,300 | $137.00 | $1,274,100.00 | (100%) 9.3K to 0 | 0% |
02-Aug-18 4:05 PM View: | Fiedler Konstantin Chief Operating Officer | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (other) | 23,582 | $137.00 | $3,230,730.00 | (88%) 26.84K to 3.25K | 0% |
02-Aug-18 4:03 PM View: | Borisy Alexis Director | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 73,173 | $137.00 | $10,024,700.00 | (100%) 73.17K to 0 | 0% |
02-Aug-18 4:05 PM View: | Fiedler Konstantin Chief Operating Officer | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 3,253 | $137.00 | $445,661.00 | (100%) 3.25K to 0 | 0% |
02-Aug-18 4:09 PM View: | Pellini Michael J Director | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 103,711 | $137.00 | $14,208,400.00 | (100%) 103.71K to 0 | 0% |
02-Aug-18 4:05 PM View: | Dougherty Michael R Director | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 12,120 | $137.00 | $1,660,440.00 | (100%) 12.12K to 0 | 0% |
02-Aug-18 4:04 PM View: | Doherty Michael J Head of Product Development | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (change in control) | 15,955 | $137.00 | $2,185,840.00 | (100%) 15.96K to 0 | 0% |
02-Aug-18 4:06 PM View: | Hesslein Robert W. SVP and General Counsel | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (other) | 28,709 | $137.00 | $3,933,130.00 | (27%) 105.2K to 76.49K | 0% |
02-Aug-18 4:03 PM View: | Civik Thomas Chief Commercial Officer | Foundation Medicine, Inc. (FMI) | 31-Jul-18 | Disposition (other) | 33,421 | $137.00 | $4,578,680.00 | (100%) 33.42K to 0 | 0% |
05-Jul-18 4:10 PM View: | Ryan Jason Chief Financial Officer | Foundation Medicine, Inc. (FMI) | 02-Jul-18 | Market Sale | 3,403 | $136.66 | $465,054.00 | (6%) 52.57K to 49.17K | (< 1%) |
05-Jul-18 4:06 PM View: | Cox Troy Chief Executive Officer Director | Foundation Medicine, Inc. (FMI) | 02-Jul-18 | Market Sale | 1,402 | $136.66 | $191,597.00 | (< 1%) 243.47K to 242.07K | (< 1%) |
05-Jul-18 4:09 PM View: | Miller Vincent A. Chief Medical Officer | Foundation Medicine, Inc. (FMI) | 02-Jul-18 | Market Sale | 2,909 | $136.66 | $397,544.00 | (4%) 70.09K to 67.18K | (< 1%) |
05-Jul-18 4:08 PM View: | Fiedler Konstantin Chief Operating Officer | Foundation Medicine, Inc. (FMI) | 02-Jul-18 | Market Sale | 994 | $136.66 | $135,840.00 | (4%) 27.83K to 26.84K | (< 1%) |
05-Jul-18 4:08 PM View: | Hesslein Robert W. SVP and General Counsel | Foundation Medicine, Inc. (FMI) | 02-Jul-18 | Market Sale | 2,520 | $136.66 | $344,383.00 | (2%) 107.72K to 105.2K | (< 1%) |
05-Jul-18 4:07 PM View: | Doherty Michael J Head of Product Development | Foundation Medicine, Inc. (FMI) | 02-Jul-18 | Market Sale | 2,675 | $136.66 | $365,566.00 | (3%) 83.96K to 81.29K | (< 1%) |
05-Jul-18 4:09 PM View: | Nallicheri Melanie Chief Business Officer | Foundation Medicine, Inc. (FMI) | 02-Jul-18 | Market Sale | 2,008 | $136.66 | $274,413.00 | (3%) 68.02K to 66.01K | (< 1%) |
19-Jun-18 4:03 PM View: | Pellini Michael J Director | Foundation Medicine, Inc. (FMI) | 15-Jun-18 | Market Sale (Planned) | 3,500 | $105.45 | $369,075.00 | (3%) 107.21K to 103.71K | (30%) |
23-May-18 4:06 PM View: | Miller Vincent A. Chief Medical Officer | Foundation Medicine, Inc. (FMI) | 21-May-18 | Option Exercise | 1,570 | $29.94 | $47,005.80 | 2% 70.09K to 71.66K | |
23-May-18 4:06 PM View: | Miller Vincent A. Chief Medical Officer | Foundation Medicine, Inc. (FMI) | 21-May-18 | Market Option Sale (Planned) | 1,570 | $85.00 | $133,450.00 | (2%) 71.66K to 70.09K | (61%) |
17-May-18 4:13 PM View: | Cox Troy Chief Executive Officer Director | Foundation Medicine, Inc. (FMI) | 16-May-18 | Market Sale (Planned) | 2,157 | $77.10 | $166,305.00 | (< 1%) 245.63K to 243.47K | (78%) |
17-May-18 4:12 PM View: | Pellini Michael J Director | Foundation Medicine, Inc. (FMI) | 15-May-18 | Market Sale (Planned) | 3,500 | $76.05 | $266,175.00 | (3%) 110.71K to 107.21K | (80%) |
09-May-18 4:04 PM View: | Cox Troy Chief Executive Officer Director | Foundation Medicine, Inc. (FMI) | 07-May-18 | Market Sale | 7,063 | $70.01 | $494,481.00 | (3%) 252.69K to 245.63K | (96%) |
18-Apr-18 4:07 PM View: | Miller Vincent A. Chief Medical Officer | Foundation Medicine, Inc. (FMI) | 16-Apr-18 | Market Sale (Planned) | 3,283 | $74.02 | $243,008.00 | (4%) 73.37K to 70.09K | (85%) |
18-Apr-18 4:08 PM View: | Ryan Jason Chief Financial Officer | Foundation Medicine, Inc. (FMI) | 16-Apr-18 | Market Sale (Planned) | 3,449 | $74.30 | $256,261.00 | (6%) 56.02K to 52.57K | (84%) |
18-Apr-18 4:08 PM View: | Pellini Michael J Director | Foundation Medicine, Inc. (FMI) | 16-Apr-18 | Market Sale (Planned) | 3,500 | $74.65 | $261,275.00 | (3%) 114.21K to 110.71K | (84%) |
05-Apr-18 4:15 PM View: | Doherty Michael J Head of Product Development | Foundation Medicine, Inc. (FMI) | 03-Apr-18 | Market Sale | 2 | $72.40 | $144.80 | (< 1%) 83.96K to 83.96K | (89%) |
05-Apr-18 4:15 PM View: | Ryan Jason Chief Financial Officer | Foundation Medicine, Inc. (FMI) | 03-Apr-18 | Market Sale | 1 | $72.40 | $72.40 | (< 1%) 56.02K to 56.02K | (89%) |
05-Apr-18 4:14 PM View: | Pellini Michael J Director | Foundation Medicine, Inc. (FMI) | 03-Apr-18 | Market Sale (Planned) | 13,659 | $70.28 | $959,954.00 | (11%) 127.87K to 114.21K | (95%) |
03-Apr-18 4:13 PM View: | Ryan Jason Chief Financial Officer | Foundation Medicine, Inc. (FMI) | 02-Apr-18 | Market Sale (Planned) | 3,109 | $77.55 | $241,103.00 | (5%) 59.13K to 56.02K | (77%) |
03-Apr-18 4:11 PM View: | Hesslein Robert W. SVP and General Counsel | Foundation Medicine, Inc. (FMI) | 02-Apr-18 | Market Option Sale | 1,585 | $74.88 | $118,685.00 | (1%) 109.31K to 107.72K | (83%) |
03-Apr-18 4:11 PM View: | Miller Vincent A. Chief Medical Officer | Foundation Medicine, Inc. (FMI) | 02-Apr-18 | Market Sale | 2,883 | $74.88 | $215,871.00 | (4%) 76.25K to 73.37K | (83%) |
03-Apr-18 4:13 PM View: | Nallicheri Melanie Chief Business Officer | Foundation Medicine, Inc. (FMI) | 02-Apr-18 | Market Sale | 1,253 | $74.88 | $93,824.60 | (2%) 69.27K to 68.02K | (83%) |
03-Apr-18 4:11 PM View: | Hesslein Robert W. SVP and General Counsel | Foundation Medicine, Inc. (FMI) | 02-Apr-18 | Option Exercise | 2,344 | $7.12 | $16,689.30 | 2% 106.96K to 109.31K | |
03-Apr-18 4:13 PM View: | Ryan Jason Chief Financial Officer | Foundation Medicine, Inc. (FMI) | 02-Apr-18 | Market Sale | 3,030 | $74.87 | $226,856.00 | (5%) 62.16K to 59.13K | (83%) |
03-Apr-18 4:09 PM View: | Doherty Michael J Head of Product Development | Foundation Medicine, Inc. (FMI) | 02-Apr-18 | Market Sale | 8,190 | $74.87 | $613,185.00 | (9%) 92.15K to 83.96K | (83%) |
03-Apr-18 4:10 PM View: | Fiedler Konstantin Chief Operating Officer | Foundation Medicine, Inc. (FMI) | 02-Apr-18 | Market Sale | 358 | $74.88 | $26,807.00 | (1%) 28.19K to 27.83K | (83%) |